MENU
Larimar Therapeutics (LRMR) Ownership - Who owns Larimar Therapeutics?
Profile
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
567.88M
P/E Ratio
N/A
Total Cash
226.06M
Projected Growth
N/A
Total Debt
5.6M
Revenue
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
3.54
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LRMR
Capitalization
568M
P/E Ratio
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
226M
Total Cash/Share
3.54
Total Debt
5.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
211M
P/B Ratio
2.69
Cash Flow
N/A
Earnings
-1.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
64K
Current Ratio
10.93
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-65.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.44
Shares Held By Institutions
531M
Shares Outstanding - Current
63.8M
Total Liabilities
25.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
95.604
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
42
Web
https://www.larimartx.com